Red Ginger's Anti-Anxiety Effect on BALB/c Strain Mice (Mus musculus) Pro-Inflammatory and Anti-Inflammatory Measurements as Anxiety Model
Main Article Content
Abstract
There is a correlation between the occurrence of anxiety and the production of inflammatory mediators, and red ginger rhizome is a well-known herbal product with a high content of phenolic and flavonoid compounds that can be used as anti-inflammatories and antioxidants. The aim of study to evaluate the effect of red ginger as antianxiety in mice (Mus musculus) BALB/c strain by measuring levels of TNF-α, IL-6 and IL-10. Anxiety model mice were carried out by giving treatment with the Forced Swimming Test (FST) for 7 days then assessed by carrying out the Elevated Plus Maze for Mice (EPM) test for one day. After the treatment, the anxiety mice model was made, followed by administration of red ginger ethanol extract therapy for 14 days. The distribution of the experimental animal model groups was divided into control groups (KN, K-, K+) and treatment groups (P, P2, P3).There was a significant difference the decreased of the TNF-α levels at the all of treatment groups with red ginger rhizome extract (P1, P2, P3) compared with the control groups (KN, K-) (p<0.05), the significantly decreased of IL-6 levels in the three doses treatment group (P1, P2, P3) compared to the control group (K-, K+) (p <0.05) and an increase in IL-10 levels in the 50 mg treatment group compared to group K -, statistically not significant (p>0.05).In overall, this study suggests that FST stimulation will create anxiety symptoms and behavior as well as impact cytokine levels, namely elevated levels of TNF-α and IL-6. Giving red ginger ethanol extract has the potential to be researched further for reducing anxiety symptoms because it can block pro-inflammatory cytokines by significantly decreased levels of TNF-α, IL-6, and increased IL-10 cytokines a brief abstract about your paper’s subject of study.
Received 06/05/2023
Revised 11/08/2023
Accepted 03/09/2023
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Boland RJ, Verduin ML, Ruiz P, Shah A. Kaplan and Sadock’s Synopsis of Psychiatry. (12th Ed.). Lippincott Williams & Wilkins (LWW), Philadelphia; 2021. 471-472.
Espiridion E, Fuchs A, Oladunjoye A. Illness Anxiety Disorder A Case Report and Brief of the literature. Cureus. 2021; 13: e12897. https://doi.org/10.7759/cureus.12897
Salama H, Alnajjar Y, AbuHeweila M, Dukmak O, Ikhmayyes I, Saadeh S. Health Anxiety by Proxy Disorder: A Case Report. Cureus. 2023;15. https://doi.org/10.7759/cureus.34058
Rynn M a., Riddle M a., Yeung PP, Kunz NR. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: Two placebo-controlled trials. Am J Psychiatry. 2007;164(2):290-300. https://doi.org/10.1176/ajp.2007.164.2.290
Toft H, Bramness J, Lien L. Levels of Peripheral Circulating IL-6 and IL-10 Decrease Over Time Despite High Depression Burden in PTSD Patients. Neuropsychiatr Dis Treat. 2022; 18: 737-747. https://doi.org/10.2147/NDT.S357797
Strawn J, Geracioti L, Rajdev N, Clemenza K, Levine A. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opin Pharmacother. 2018; 19: 1057-1070. https://doi.org/10.1080/14656566.2018.1491966
Wedekind D, Bandelow B. Trends in the treatment of anxiety disorders. PsychoNeuro. 2005; 31: 499-503.
Halder S, Anand U, Nandy S, et al. Herbal drugs and natural bioactive products as potential therapeutics: A review on pro-cognitives and brain boosters perspectives. Saudi Pharm J. 2021; 29(8): 879-907. https://doi.org/10.1016/j.jsps.2021.07.003
Supu R, Diantini A, Levita J. RED GINGER (Zingiber officinale var. rubrum): Its Chemical Constituents, Pharmacological Activities and Safety . Fitofarmaka J Ilm Farm. 2019; 8: 23-29. https://doi.org/10.33751/jf.v8i1.1168
Ghafoor K, AL Juhaimi F, Özcan M, Uslu N, Babiker E, Mohamed Ahmed I. Total phenolics, total carotenoids, individual phenolics and antioxidant activity of ginger (Zingiber officinale) rhizome as affected by drying methods. LWT. 2020; 126: 109354. https://doi.org/10.1016/j.lwt.2020.109354
Ünal G, Canbeyli R. Psychomotor Retardation in Depression: A Critical Measure of the Forced Swim Test. Behav Brain Res. 2019;372:112047. https://doi.org/10.1016/j.bbr.2019.112047
Gorman-Sandler E, Hollis F. The forced swim test: Giving up on behavioral despair (Commentary on Molendijk & de Kloet, 2021). Eur J Neurosci. 2022; 55(9-10): 2832-2835. https://doi.org/10.1111/ejn.15270
Rosas-Sánchez G, German-Ponciano L, Rodríguez-Landa JF. Considerations of Pool Dimensions in the Forced Swim Test in Predicting the Potential Antidepressant Activity of Drugs. Front Behav Neurosci. 2022; 15: 1-7. https://doi.org/10.3389/fnbeh.2021.757348
Lima B, Patriota L, Marinho A, et al. The Anxiolytic Activity of Schinus terebinthifolia Leaf Lectin (SteLL) Is Dependent on Monoaminergic Signaling although Independent of the Carbohydrate-Binding Domain of the Lectin. Pharmaceuticals. 2022;15:1364. https://doi.org/10.3390/ph15111364
Andreatini R, Bacellar LFS. The relationship between anxiety and depression in animal models: A study using the forced swimming test and elevated plus-maze. Braz J Med Biol Res. 1999; 32: 1121-1126. https://doi.org/10.1590/S0100-879X1999000900011
Santoft F, Hedman E, Salomonsson S, et al. Inflammatory Cytokines in Patients with Common Mental Disorders Treated with Cognitive Behavior Therapy. Brain Behav Immun - Heal. 2020; 3: 100045. https://doi.org/10.1016/j.bbih.2020.100045
Knight JM, Costanzo ES, Singh S, et al. The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill. Transl Psychiatry. 2021;11(1):58. https://doi.org/10.1038/s41398-020-01164-y
Mac Giollabhui N. Inflammation and depression: Research designs to better understand the mechanistic relationships between depression, inflammation, cognitive dysfunction, and their shared risk factors. Brain Behav Immun - Heal. 2021; 15: 100278. https://doi.org/10.1016/j.bbih.2021.100278
Khalied Mohammed S, Taha M, Taha E, Mohammad M. Cluster Analysis of Biochemical Markers as Predictor of COVID-19 Severity. Baghdad Sci J. 2022; 19: 1423. https://doi.org/10.21123/bsj.2022.7454
Alshammari MA, Khan MR, Majid Mahmood H, et al. Systemic TNF-α blockade attenuates anxiety and depressive-like behaviors in db/db mice through downregulation of inflammatory signaling in peripheral immune cells. Saudi Pharm J. 2020; 28(5): 621-629. https://doi.org/10.1016/j.jsps.2020.04.001
Dib P, Zhang Y, Ihnat M, Gallucci R, Standifer K. TNF-Alpha as an Initiator of Allodynia and Anxiety-Like Behaviors in a Preclinical Model of PTSD and Comorbid Pain. Front Psychiatry. 2021; 12: 721999. https://doi.org/10.3389/fpsyt.2021.721999
Uzzan S, Azab A. Anti-TNF-α Compounds as a Treatment for Depression. Molecules. 2021; 26: 2368. https://doi.org/10.3390/molecules26082368
Al-Hassnawi ATS, Al-Morshidy KAH, Al-Harbi NY. Milk tumor necrosis factor alpha and interleukin-1beta among toxoplasma gondii-free and infected women. Baghdad Sci J. 2022; 19(1): 1-6. https://doi.org/10.21123/BSJ.2022.19.1.0001
Amer SAAM, Fouad AM, El-Samahy M, et al. Mental Stress, Anxiety and Depressive Symptoms and Interleuken-6 Level among Healthcare Workers during the COVID-19 Pandemic. J prim care amp community Health. 2021;12:21501327211027430. https://doi.org/10.1177/21501327211027432
Ting E, Yang A, Tsai SJ. Role of Interleukin-6 in Depressive Disorder. Int J Mol Sci. 2020; 21: 2194. https://doi.org/10.3390/ijms21062194
Darcy J, Tseng YH. The Link between Stress and IL-6 Is Heating Up. Cell Metab. 2020; 32: 152-153. https://doi.org/10.1016/j.cmet.2020.07.011
Munshi S, Parrilli V, Rosenkranz J. Peripheral Anti-inflammatory Cytokine Interleukin-10 Treatment Mitigates Interleukin-1β - Induced Anxiety And Sickness Behaviors in Adult Male Rats. Behav Brain Res. 2019; 372: 112024. https://doi.org/10.1016/j.bbr.2019.112024